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Previous research exploring pathophysiological mechanisms underlying circulatory
collapse after rewarming victims of severe accidental hypothermia has documented
post-hypothermic cardiac dysfunction and hypothermia-induced elevation of intra-
cellular Ca2+ concentration ([Ca2+]i) in myocardial cells. The aim of the present
study was to examine if maintaining euvolaemia during rewarming mitigates cardiac
dysfunction and/or normalizes elevated myocardial [Ca2+]i. A total of 21 male Wistar
rats (300 g) were surface cooled to 15◦C, then maintained at 15◦C for 4 h, and sub-
sequently rewarmed to 37◦C. The rats were randomly assigned to one of three groups:
(1) non-intervention control (n = 7), (2) dextran treated (i.v. 12 ml/kg dextran 70;
n = 7), or (3) crystalloid treated (24 ml/kg 0.9% i.v. saline; n = 7). Infusions occurred
during the first 30 min of rewarming. Arterial blood pressure, stroke volume (SV),
cardiac output (CO), contractility (dP/dtmax) and blood gas changes were measured.
Post-hypothermic changes in [Ca2+]i weremeasured using themethod of radiolabelled
Ca2+ (45Ca2+). Untreated controls displayed post-hypothermic cardiac dysfunction
with significantly reduced CO, SV and dP/dtmax. In contrast, rats receiving crystalloid
or dextran treatment showed a return to pre-hypothermic control levels of CO and SV
after rewarming, with the dextran group displaying significantly better amelioration
of post-hypothermic cardiac dysfunction than the crystalloid group. Compared to the
post-hypothermic increase inmyocardial [Ca2+]i in non-treated controls, [Ca
2+]i values
with crystalloid and dextran did not increase to the same extent after rewarming.
Volume replacement with crystalloid or dextran during rewarming abolishes post-
hypothermic cardiac dysfunction, and partially mitigates the hypothermia-induced
elevation of [Ca2+]i.
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1 INTRODUCTION
Successful rewarming of patients after accidental hypothermia is
often complicated by hypothermia-induced myocardial dysfunction,
clinically ranging from a minor depression of cardiac output (CO)
to a fulminant circulatory collapse (‘rewarming shock’) (Maclean &
Emslie-Smith, 1977; Tveita, 2000). Hypothermia-induced myocardial
dysfunction presents as a left ventricular systolic dysfunction during
and after rewarming (Filseth et al., 2010). The pathophysiological
mechanisms are not completely understood, but preclinical
experiments have revealed that at least part of the dysfunction is
caused by impairment of the contractile apparatus within cardio-
myocytes. In addition, significant elevation of intracellular [Ca2+]
([Ca2+]i) takes place during hypothermia (Wold et al., 2013), and it
remains elevated after rewarming (Kondratiev et al., 2008;Wold et al.,
2013).
Depending on the depth and severity of hypothermic exposure,
cooling and rewarming can disrupt a number of physiological
processes. For example, in response to cooling, there are changes
in circulatory parameters, which include a progressive reduction of
heart rate (HR), mean arterial pressure (MAP) and CO (Filseth et al.,
2010; Tveita et al., 1996). Furthermore, there is a profound increase
in blood viscosity during hypothermia, which gives rise to a marked
elevation of total peripheral resistance (TPR) that is aggravated by
a simultaneous increase in vascular tone (Brown et al., 2012). The
resulting low-flow state induced by cooling disrupts shear forces and
can lead to intravascular aggregation of red blood cells, which has
been demonstrated in hypothermic microcirculation (Grossman &
Lewis, 1964; Lofstrom, 1959). These red blood cell aggregates can
become lodged at the entrance to capillaries and block flow through
individual micro-vessels, impairing effective circulation as red blood
cells are sequestered in peripheral tissues (Lipowsky, 2005). Along
with a hypothermia-induced impairment of the vascular barrier and
a subsequent increase in fluid extravasation from the intravascular
to the interstitial space (Hammersborg et al., 2005), there may be a
significant loss of plasma volume and circulating blood volume in the
hypothermic patient.
It remains unclear whether hypovolaemia is an essential factor
in rewarming shock (Tveita, 2000). Based on the observation that
hypothermia-induced loss of plasma volume and circulating blood
volume may reverse upon rewarming, some have advocated caution
against administering large volumes of fluid to accidental hypothermia
patients (Lloyd, 1996). However, there is preclinical evidence that fluid
loss does not necessarily resolve, especially after prolonged hypo-
thermic exposure (Kondratiev et al., 2006; Tveita et al., 1996). Thus,
to avoid intravascular hypovolaemia during rewarming, fluid loss must
be compensated by fluid administration, and often in considerable
amounts (Brown et al., 2012; Farstad & Husby, 2014; Paal et al., 2016;
Truhlar et al., 2015). Still, there is a lack of consensus concerning
the type of fluid to be given, with some recommending liberal use of
warm crystalloid solutions (Brown et al., 2012), while others routinely
administer colloid solutions only during rewarming from severe hypo-
thermia (Farstad et al., 2006; Suominen et al., 2010). Compared
New Findings
∙ What is the central question of this study?
Detailed guidelines for volume replacement to
counteract hypothermia-induced intravascular
fluid loss are lacking. Evidence suggests colloids
might have beneficial effects compared to crystal-
loids. Are central haemodynamic function and
level of hypothermia-induced calcium overload,
as a marker of cardiac injury, restored by fluid
substitution during rewarming, and are colloids
favourable to crystalloids?
∙ What is themain finding and its importance?
Infusion with crystalloid or dextran during re-
warming abolished post-hypothermic cardiac dys-
function, andpartiallymitigatedmyocardial calcium
overload. The effects of volume replacement to
support haemodynamic function are comparable
to those using potent cardio-active drugs. These
findings underline the importance of applying
intravascular volume replacement to maintain
euvolaemia during rewarming.
to crystalloid solutions, administering colloids during rewarming
from hypothermia is associated with improved post-hypothermic
haemodynamic function, and reported to limit oedema formation and
total fluid requirements (Farstad&Husby, 2014).Dextrans, specifically,
are demonstrated to counteract the formation of red blood cell
aggregates in the hypothermic microcirculation (Lofstrom, 1959).
In a rat model of hypothermia–rewarming shock, we previously
observed post-hypothermic reductions in CO and stroke volume (SV),
as well as a 15–20% loss of circulating blood volume after rewarming
(Kondratiev et al., 2006). In the present study, we hypothesized that
post-hypothermic myocardial dysfunction and elevation of [Ca2+]i is
mitigated by maintaining euvolaemia during rewarming, and that the




Adult male Wistar rats (250–350 g; Harlan UK Ltd, UK) were used
in the present study. The experimental protocol was approved by
the Norwegian Animal Research Authority (ref. no.: 08/62182-1) in
accordance with the recommendations of the Federation of European
Laboratory Animal Science Associations. On arrival, the animals were
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quarantined for 1 week, provided ad libitum access to food and water,
and housed in accordancewith guidelines for accommodation and care
of animals (article 5 of the European Convention for the Protection
of Vertebrate Animals used for Experimental and Other Scientific
Purposes, Strasbourg, 18.III.1986).
2.2 Anaesthesia
Anaesthesia was induced by an i.p. injection of 50mg/kg pentobarbital
sodium, followed by a continuous infusion of 7.5 mg/kg/h through
an intravenous line in the right jugular vein, extended to the right
auricle. Due to hypothermia-induced anaesthesia and reduced drug
metabolism, infusion was terminated at temperatures <30◦C during
cooling, and reintroduced at 30◦C during rewarming. Animals were
continuously monitored by toe-pinch for any sign of discomfort, and
additional anaesthesia was provided if necessary. No neuromuscular
blockerswereusedat any timeduring theexperiment.After rewarming
to 37◦C and subsequent data sampling, animals were euthanised by an
i.v. injection of 1ml pentobarbital sodium (50mg/ml).
2.3 Respiratory support
The rats were placed on an operating table in the supine position. The
trachea was incised, and a 14 G tracheal tube inserted. All animals had
spontaneous and sufficient ventilation (monitored by PaCO2 ) at core
temperatures>20◦C. At core temperatures<20◦C, normo-ventilation
(PaCO2 , 5.18–6.39 kPa) was achieved by a volume-controlled small-
animal respirator (New England rodent ventilator, model 141, New
England Instruments, Medway,MA, USA) using room air.
2.4 Core cooling and rewarming
Animals were cooled and rewarmed by circulation of cold or warm
water (recirculating water bath heater, RTE-110, Neslab Instruments,
Newington, NH, USA) through U-shaped polyethylene tubes placed
in the oesophagus and the lower bowels. Also, water from the same
water bath circulated through thedouble layeredoperating tablemade
of hollow aluminium. Core temperature was continuously monitored
using a thermocouple wire positioned in the aortic arch via the right
femoral artery, connected to a thermocouple controller (Thermoalert
TH-5, Columbus Instruments, Columbus, OH, USA).
2.5 Haemodynamic measurements
Previously, we used a pressure–volume conductance catheter to
monitor left ventricular cardiac function. However, in the present
experiment, as a consequence of infusing relatively large intravenous
volumes, significant changes in the electrical conductance of bloodpre-
cluded reliable volume measurements using this conductance cather.
Therefore, COwasmeasured using the thermodilution technique, first
described by Fegler (1954), by injecting 0.1–0.15ml of 0.9% saline pre-
cooled in ice water through an intravenous line positioned in the right
auricle. The change in temperature was recorded from the thermo-
couple positioned in the aortic arch. Thermodilution signals were
recorded on a Linearcorder (Mark II,WR3101,Watanabe Instruments,
Tokyo, Japan), digitalized (at 1 kHz sampling rate) using a Calcomp
digitizing table (model 23180, Calcomp Digitzer Products Division,
Anaheim, CA, USA) and analysedwithout further signal processing. CO
was calculated according to themethod described byHanwell & Linzell
(1972), with a program designed with the LabView package (LabVIEW
6.0, National Instruments, Austin, TX, USA) and calculated as themean
of three consecutive measurements.
A 22 G, fluid-filled catheter was placed in the left femoral artery for
continuous recording of arterial pressure. The signals from the blood
pressure transducer were amplified and digitized (12-bit analog-to-
digital converter; BNC2090,National Instruments) at a 1 kHz sampling
rate. Signal processing and data analysis were performedwith the help
of a unique computer program developed at our department using a
LabView package.
2.6 Blood gases and acid–base parameters
Blood gases, O2 saturation, pH and base excess were measured in
0.15 ml arterial blood samples taken from the femoral artery at
the start of the experiment, at 15◦C, and after rewarming to 37◦C.
Samples were analysed by a RapidLab 800 blood gas analyser (Chiron
Diagnostics, Emeryville, CA, USA).
2.7 Measurement of [Ca2+]i
Total myocardial [Ca2+]i was measured using a method previously
described in detail (Kondratiev et al., 2008), which was based on the
incorporation of radiolabelled Ca2+ (45Ca2+) and adapted to an in vivo
experiment. In brief, 20 µCi of 45Ca2+ (ARX-102Calcium-45, American
Raidolabeled Chemicals Inc., St Louis, MO, USA) was injected at the
start of the experiment. Pilot experiments revealed a rapid reduction of
45Ca2+ activity in the plasma, reaching a steady state level by 120 min
after injection. In order to wash out extracellular 45Ca2+ in the myo-
cardium, the heartswere excised and perfused in a Langendorff system
with Krebs–Hensleit bicarbonate buffer containing 11.1 mM glucose
and 2.4 mM Ca2+ at room temperature. We found that extracellular
45Ca2+ was washed out after 1 min, and a washout period of 3 min
was chosen, after which the hearts were freeze clamped, vacuum
dry frosted (Christ Alpha 1–4; Medizinischer Apparatebau, Osterode,
Harz,Germany) and subsequently pulverizedby amicro-dismembrator
(Braun Messungen AG, Melsungen, Germany). In the homogenate,
80–90 mg was extracted in perchloric acid, centrifuged at 7000g
(Kubota 1700 centrifuge; Cubota Corp., Tokyo, Japan), and the 45Ca2+
activity in the supernatant was determined. To determine the specific
activity of the isotope, an arterial blood sample, drawn immediately
before terminating the experiment, was centrifuged at 9000g, and the
45Ca2+ activity and Ca2+ concentration in plasma were determined
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F IGURE 1 Experimental protocol
using a liquid scintillation spectrometer (Model 1900 TR, Packard
Instrument Co., Downers Grove, IL, USA) and RapidLab 800 blood gas
analyser (Chiron Diagnostics Corp.) respectively. Ultimately, [Ca2+]i
was calculated from the tissue radioactivity, the specific activity of the
plasma and the dry weight of the heart tissue. As this method cannot
distinguish between intracellular Ca2+ compartments, that is, cyto-
solic, sarcoplasmic reticulum and mitochondrial, only total myocardial
[Ca2+]i wasmeasured.
2.8 Blood volume determination
Blood volume was determined at the end of the experiment using the
method described by Tschaikowsky et al. (1997), in which hydroxyl
ethyl starch (HES) is used as a dilution marker. Blood (0.4 ml) was
drawn from the arterial line just before injection of 0.5 ml of HES into
the venous line and again 5 min after the injection. Haematocrit was
determined 5 min after injection of HES that had been centrifuged
at 11400g (Centri A 13, Jouan, Saint Nazaire, France) for 5 min at
12,000 rpm. From the same blood samples, plasma glucose levels
were determined. In accordance to the method of Tschaikowsky et al.
(1997), concentrated HCl was added to plasma samples to hydrolyse
glucose from HES. Plasma glucose was determined by the Cobas Fara
II Chemistry System using a glucose kit (Roche Diagnostics, Basel,
Switzerland). Total blood volume (BV) was determined as follows:
BV = 3082 × VolHES/Δglucose/(1 − Hct), where Δglucose is the
difference in plasma glucose levels before and after HES (mg%), 3082
(mg%) is a standard factor given by Tschaikowsky et al. (1997), and
VolHES is the volume of HES injected (ml).
After surgical instrumentation, animals were allowed to rest
for 45 min before starting the experiment and obtaining base-
line measurements. After cooling and the 4-h period at 15◦C,
animals were randomized into one of three experimental groups
(Figure 1):
Group 1 (n = 7), non-intervention control. The animals were cooled
from 37◦C to 15◦C during a 100-min period, maintained at 15◦C for 4
h, and then rewarmed over a 100-min period before being euthanised.
No intravenous fluids were given except the fluids accompanying
anaesthesia.
Group2 (n=7), dextran treated. Theanimalswere cooled from37◦C
to 15◦C during a 100-min period, maintained at 15◦C for 4 h, and then
rewarmed over a 100-min period before being euthanised. During the
rewarming period, these animals were given an i.v. infusion of 12ml/kg
dextran 70 (60 mg/ml dextran in 0.9% saline) in addition to the fluids
accompanying anaesthesia.
Group 3 (n = 7), crystalloid treated. The animals were cooled from
37◦C to 15◦C during a 100-min period, maintained at 15◦C for 4 h,
and then rewarmed over a 100-min period before being euthanised.
During the rewarming period, these animals were given an i.v. infusion
of 25 ml/kg 0.9% saline, in addition to the fluids accompanying
anaesthesia.
2.9 Calculations
Stroke volume (SV) was calculated as: CO/HR. TPR was calculated as:
MAP/CO.
2.10 Statistics
Results are presented as means and SD. Hemodynamic variables
in Figure 4 and 5, and myocardial [Ca2+]i values in Figure 6 are
presented as median with interquartile range, 10th and 90th
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F IGURE 2 Haemodynamic function during hypothermia and rewarming. (a) Cardiac output (CO); (b) stroke volume (SV); (c) total peripheral
resistance (TPR). Values aremeans± SD. Each group n= 7; * P< 0.05 vs. corresponding value in the non-intervention control group; †P< 0.05 vs.
corresponding value in the crystalloid group
percentile. For between-group comparisons of haemodynamic
variables and myocardial [Ca2+]i, a one-way ANOVA was used. When
significant differences were found, P-values were obtained by using
Scheffe’s test in hypothermic groups. For within-group comparisons of
normothermic baseline against post-hypothermic end point, a paired
Student’s t-test was used. To compare variables measured in plasma
samples, a two-way RMANOVAwith Dunnett’s post hoc test was used.
Differences were considered significant at P< 0.05.
3 RESULTS
3.1 Haemodynamic function (Figures 2 and 3)
As in previous studies using this animal model (Haheim et al., 2017;
Wold et al., 2013), we found that haemodynamic function was
stable during normothermic conditions. There were no differences
in pre-hypothermic baseline haemodynamic values among the three
groups.
3.1.1 Cooling and 4 h at 15◦C
Compared to pre-hypothermic baseline, cooling to 15◦C caused
a reduction in most haemodynamic variables. Due to technical
limitations related to both the conductance catheter and thermo-
dilution techniques, CO could not be measured below 20◦C, and
consequently, calculations of TPR and SV could not be made below
this temperature. At 20◦C a substantial reduction in COwasmeasured
(∼50%; Figure 2a), whereas TPR remained unchanged (Figure 2c),
and SV was increased (∼200%; Figure 2b). At 15◦C the following
haemodynamic variables were substantially reduced: HR (∼87%;
Figure 3a), MAP (∼57%; Figure 3b), dP/dtmax (∼88%; Figure 3c) and
dP/dtmin (∼93%; Figure 3d). No further changes were measured in
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F IGURE 3 Haemodynamic function during hypothermia and rewarming (cont.). (a) Heart rate (HR); (b) mean arterial pressure (MAP);
(c) maximum rate of LV pressure rise (dP/dtmax); (d) maximum rate of LV pressure decline (dP/dtmin). Values aremeans± SD. Each group, n= 7; *
P< 0.05 compared to corresponding value in the non-intervention control group; †P< 0.05 compared to corresponding value in the crystalloid
group
any of the haemodynamic variables during 4-h maintenance of core
temperature at 15◦C.
3.1.2 Rewarming to 37◦C
Comparisons among groups
In the dextran-treated group, COwas significantly increased compared
to both the crystalloid-treated and the non-intervention groups, and
remained elevated throughout rewarming to 37◦C (Figure 2a). In
response to cooling and rewarming,HRunderwent substantial changes
(Figure 3a), but there was no differences among groups in HR, and
therefore, the increase in CO in response to dextran was due to
the significant increase in SV (Figure 2b), over that of the two other
groups, during rewarming. In contrast, in the crystalloid-treated group,
there was a significant increases in CO and SV compared to the non-
intervention group, but these effects lasted only half way through the
100min rewarming period (Figure 2a, b).
3.1.3 Pre-hypothermic versus post-hypothermic
differences (Figures 4 and 5)
In contrast to the non-intervention group, where there were
significant reductions in CO (Figure 4a), SV (Figure 4b), and the
index of left ventricular contractility, dP/dtmax (Figure 5c) after
rewarming, all of these haemodynamic variables returned to pre-
hypothermic baseline values after rewarming in both treatment
groups.
3.2 Post-hypothermic myocardial [Ca2+]i
(Figure 6)
Compared to the non-intervention control group, post-hypothermic
myocardial [Ca2+]i was significantly lower in both the crystalloid-
treated (−47%) and the dextran-treated (−49%) groups.
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F IGURE 4 Pre-hypothermic vs. post-hypothermic haemodynamic function. (a) Cardiac output (CO); (b) stroke volume (SV); (c) total peripheral
resistance (TPR). BL, pre-hypothermic baseline; RW, after rewarming to 37◦C. Each group, n= 7. Values are presented as vertical boxes with
median (solid line), mean (dashed line), interquartile range with 10th and 90th percentile error bars. #P< 0.05 vs. intragroup pre-hypothermic
baseline
3.3 Post-hypothermic arterial gas levels (Table 1)
Compared to their corresponding pre-hypothermic values, cooling to
15◦C was associated with a significant reduction in pH in all groups.
In the crystalloid-treated group, there was an elevation of PaCO2 , but
withinphysiological levels. Baseexcess (BE)was lower in the crystalloid
and dextran-treated groups compared to the non-intervention control
group.
After rewarming, when compared to their corresponding pre-
hypothermic control values, animals in all groups demonstrated
a significant increase in serum lactate levels in concert with
reduced BE and pH, and a compensatory hyperventilation. Blood
volume was measured in the non-intervention control group and
the crystalloid-treated group only, but no differences between
the two groups were found after rewarming. There were no
differences among groups in post-hypothermic levels of serum
cardiac troponin I. However, these levels were elevated (7−10 times)
when compared to levels previously reported for normothermic
time-matched control animals (Dietrichs et al., 2014). This suggests
that hypothermia/rewarming induces cardiac tissue damage in this
model.
4 DISCUSSION
This study demonstrated that intravenous volume replacement, using
crystalloid or dextran treatment during rewarming from hypothermia,
significantly improved post-hypothermic haemodynamic function and
mitigated the hypothermia-induced elevation of myocardial [Ca2+]i.
This is in contrast to non-intervention control animals in which
hypothermia/rewarming induced reductions in SV, CO, dP/dtmax, and
significantly higher [Ca2+]i. In the crystalloid-treated group, the effects
of volume replacement to support haemodynamic functionwas limited
to the period of fluid administration, whereas in the dextran-treated
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F IGURE 5 Pre-hypothermic vs. post-hypothermic haemodynamic function (cont.). (a) Heart rate (HR); (b) mean arterial pressure (MAP);
(c) maximum rate of LV pressure rise (dP/dtmax); (d) maximum rate of LV pressure decline (dP/dtmin). Each group, n= 7. Values are are presented as
vertical boxes withmedian (solid line), mean (dashed line), interquartile range with 10th and 90th percentile error bars. #P< 0.05 vs. intragroup
pre-hypothermic baseline
group the improved haemodynamic function remained throughout
rewarming.
The effects of volume replacement during rewarming to elevate
cardiac mechanical function and contractility are comparable to those
of previous experiments documented in response to pharmacological
interventions (Dietrichs et al., 2014; Kondratiev et al., 2006; Tveita &
Sieck, 2012). However, in this study the actual intervention protocol
prevented us from using the conductance catheter, which is otherwise
routinely used in this experimental model. Therefore, continuous
detailed information about left ventricular pressure/volume changes
in response to volume infusions could not be monitored and this
challenged our detailed interpretation of causal effects of this
treatment.
Rewarming fromhypothermia and reperfusion after hypo-perfusion
or ischaemia during normothermia share the same treatment
strategy: restoration of macro-vascular perfusion in an attempt
to optimize micro-vascular blood flow. Essential determinants of
micro-vascular blood flow are plasma viscosity, haematocrit, red blood
cell deformability and red blood cell aggregation (Surgenor, 2013). All
of these determinants are seriously affected during low-flow hypo-
thermia. As a consequence, rewarming is often challenged by amarked
elevation of SVR (Brown et al., 2012), microvascular aggregation of red
blood cells (Grossman & Lewis, 1964; Lipowsky, 2005; Lofstrom, 1959)
and fluid extravasation (Hammersborg et al., 2005), causing plasma
volume loss and subsequent reduction of circulating blood volume
(Chen & Chien, 1978; Farstad et al., 2003). The presence of red blood
cell aggregates creates a situation of heterogeneous micro-vascular
blood flow where perfused capillaries appear in close proximity to
non-perfused capillaries (Lofstrom, 1959; Svanes, 1966), causing
organ hypoxia despite normalized global O2 transport and CO during
rewarming.
In the present study, a plausible explanation for the effects of
intravenous volume replacement during rewarming in mitigating
reduced haemodynamic function appears straightforward. However,
a causal relationship between intravenous volume replacement and
the mitigation of hypothermia/rewarming-induced myocardial [Ca2+]i
overload is not as obvious. In animals receiving crystalloid or dextran
treatment, the increased circulating blood volumewill increase venous
return thereby increasing preload, which will subsequently elevate
SV and improve contractility via the Frank–Starling mechanism
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TABLE 1 Variables measured in plasma samples
Parameter Group Pre-hypothermic 15◦C Post-hypothermic
pH Control 7.36 (0.05) 7.24 (0.07)# 7.20 (0.06)#
Crystalloid 7.35 (0.02) 7.18 (0.07)# 7.21 (0.06)#
Dextran 7.33 (0.03) 7.21 (0.08)# 7.26 (0.03)#
PaCO2 (kPa) Control 4.0 (0.66) 5.0 (0.88) 2.8 (0.36)
Crystalloid 4.4 (0.42) 6.2 (1.67)# 2.9 (0.33)#
Dextran 4.3 (0.18) 5.4 (1.27) 3.3 (0.65)
PaO2 (kPa) Control 11.1 (4.1) 22.3 (6.3)
# 12.9 (3.6)
Crystalloid 10.6 (1.3) 26.9 (5.0)# 11.7 (2.1)
Dextran 10.2 (1.7) 23.4 (5.9)# 10.8 (3.1)
Hb (g/dl) Control 11.7 (1.2) 11.2 (2.0) 11.3 (1.8)
Crystalloid 12.8 (1.4) 11.1 (1.5) 11.5 (1.6)
Dextran 11.3 (1.0) 11.3 (1.1) 9.9 (1.5)
Hct (%) Control 36.2 (3.7) 36.1 (3.7) 34.8 (5.5)
Crystalloid 39.2 (4.1) 34.1 (4.4) 35.4 (4.8)
Dextran 34.8 (3.0) 35.0 (3.1) 31.3 (4.5)
Lactate (mmol/l) Control 1.3 (0.6) 0.9 (0.4) 3.5 (1.3)#
Crystalloid 2.0 (1.3) 1.7 (0.8) 4.0 (1.2)#
Dextran 1.3 (0.9) 1.6 (0.7) 3.7 (2.0)#
BE (mmol/l) Control −7.2 (1.7) −7.0 (7.0) −18.8 (2.3)#
Crystalloid −7.1 (1.5) −10.6 (2.0)* −18.3 (2.2)#
Dextran −7.9 (1.7) −11.3 (2.0)#* −15.1 (2.2)#
cTn-I (ng/ml) Control — — 10 (5.6)
Crystalloid 14.1 (7.8)
Dextran 9.8 (5.8)
CBV (ml) Control (n= 5) — — 18.7 (5.3)
Crystalloid (n= 7) 20.1 (6.4)
Dextran —
Values aremeans (SD), n= 7; *P< 0.05 compared to non-intervention control group; #P< 0.05 compared to pre-hypothermic baseline. BE, base excess; CBV,
circulating blood volume; cTn-I, cardiac troponin I; Hb, haemoglobin; HCT, haematocrit.
(Guyton, 1977). This fundamental property of the heart, by some
researchers suggested to be the consequence of increased myo-
filament Ca2+ sensitivity at longer sarcomere lengths (de Tombe
et al., 2010), would oppose the reduced Ca2+ sensitivity induced by
hypothermia–rewarming (Han et al., 2010, 2018; Schaible et al., 2016;
Tveita et al., 2019).
During volume infusion, there was a significant increase in SV,
CO and heart work, which would provide an increase in coronary
blood flow. The absence of an increase in serum lactate levels during
rewarming, over that innon-treated control, indicates thepresenceof a
patent coronary autoregulation to provide an adequate myocardial O2
supply–consumption balance to meet the increased heart work during
volume replacement. In this case, volume replacement might have
increased myocardial microcirculation, which, in the dextran-treated
group, remained throughout the rewarming phase. To speculate, an
increase in myocardial micro-vascular blood flow in response to
volume infusion also suggests increased clearance of the hypothermia-
induced [Ca2+]i overload. In support of this suggestion is the well-
documented (Fukusumi & Adolph, 1970; Grossman & Lewis, 1964;
Lofstrom, 1959) positive effect of dextran treatment in preventing
hypothermia-induced red blood cell aggregates, which is the back-
ground for using dextran in the present experiment.
Intravenous volume replacement during rewarming should
preferentially correct intravascular hypovolaemia, restore micro-
circulatory function, while limiting oedema formation and fluid
overload, factors which in clinical medicine are related to increased
patient mortality (Chappell et al., 2008).
By adding crystalloid solutions during normothermia, the intra-
vascular volume effect is only about 20%, as crystalloids are evenly
distributed throughout the extracellular fluid compartment (Chappell
et al., 2008), and this effect may be further reduced by hypothermia
(Schanche et al., 2019; Roberts et al., 1985). In contrast, infusing colloid
solutions reduces fluid extravasation and oedema formation during
hypothermia, and these solutions are routinely administered during
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F IGURE 6 Concentration of [Ca2+]i in cardiac tissue in
normothermic controls and after rewarming. Each group, n= 7. Values
are presented as vertical boxes withmedian (solid line), mean (dashed
line), interquartile range with 10th and 90th percentile error bars.
*P< 0.05 vs. non-intervention control. Normothermic control values
included are from previous studies to illustrate normothermic baseline
levels of [Ca2+]i concentration (Kondratiev et al., 2008;Wold et al.,
2013)
rewarming from severe hypothermia in some institutions (Farstad
et al., 2006; Suominen et al., 2010). Still, the fear of potential side
effects such as allergic reactions, coagulopathies and risk of kidney
injury, has led to restricted use of synthetic colloids in critically
ill patients (Reinhart et al., 2012). Several recent studies, including
information on normothermic trauma victims and critically ill patients,
has shown that a ratio of crystalloids to colloids necessary to achieve
the same physiological targets is about 1.5:1 (Annane et al., 2013;
Orbegozo et al., 2015; Spahn et al., 2019). Based on this, we chose to
use a 2:1 crystalloid to colloid ratio in the present study.
The maintenance of euvolaemia during rewarming in the treatment
groupswas indicatedby the fact that haematocrit levels didnot change,
that is, there was no evidence of haemodilution. Due to technical
limitations, circulating plasma volumesweremeasured only in the non-
intervention control and crystalloid-treated groups, but there was no
difference in circulating blood volume between these two groups after
rewarming. This may be the consequence of increased extravasation
of crystalloids at low core temperatures (Farstad et al., 2005, 2006),
limiting the volume effect only to the period of ongoing infusion, also
indicated by the temporary mitigating effect of crystalloid treatment
on haemodynamic function. The moderate but significant reduction in
pHand elevated plasma lactate levels in all groups indicate the absence
of massive organ hypoxia during hypothermia/rewarming. In support,
we found normal values of global O2 partial pressure in arterial blood.
In previous studies using animal models of hypothermia/rewar-
ming, we observed time-dependent elevation of myocardial [Ca2+]i
(Kondratiev et al., 2008;Woldet al., 2013). After 30minat15◦C [Ca2+]i
remained unaltered (Wold et al., 2013), whereas after 4 h at 15◦C,
there was a more than six-fold increase in [Ca2+]i compared to pre-
hypothermic levels (Wold et al., 2013). After rewarming, myocardial
[Ca2+]i only partially recovered (−15%), but remained substantially
increased (Wold et al., 2013). The post-hypothermic elevation of myo-
cardial [Ca2+]i levels observed in non-intervention control animals
in the present study were comparable to those previously reported
(Kondratiev et al., 2008; Wold et al., 2013). Importantly, with volume
replacement in the treatment groups, myocardial [Ca2+]i levels
were significantly lower after rewarming when compared to the
non-intervention control group. Impaired homeostasis of myocardial
[Ca2+]i is a key factor in the pathophysiology of normothermic heart
failure (Vassalle & Lin, 2004). In response to hypothermia, there is a
decrease in myofilamental Ca2+-sensitivity (Han et al., 2010, 2018;
Harrison & Bers, 1989; Schaible et al., 2016; Tveita et al., 2019).
These two, seemingly contradictory functional changes, are already
present at 30◦C (Kusuoka et al., 1991), and the increase in force is
associated with an elevation of [Ca2+]i (Puglisi et al., 1996) in response
to cooling. The increase in cytoplasmic [Ca2+] enhances cardiac contra-
ctility by increasing the number of cross-bridges recruited for force
development, but seemingly, due to a dysfunctional elevation of this
ion over time, Ca2+ overload occurs (Tani & Neely, 1989; Vassalle &
Lin, 2004), which results in mechanical dysfunction that may entail
cardiac failure (Aasum & Larsen, 1997; Aasum et al., 1997; Bers et al.,
1989; Gambassi et al., 1994; Puglisi et al., 1996; Schiffmann et al.,
2001; Shattock & Bers, 1987; Shutt & Howlett, 2008; Steigen et al.,
1994; Stowe et al., 1995, 1999, 2000; Groban et al., 2002). Studies
using papillary muscle (Han et al., 2010) or isolated cardiomyocytes
(Schaible et al., 2016) to investigate excitation–contraction coupling
at low temperatures (15◦C) have reported that the mechanism for
the hypothermia-induced calcium overload over time is related to
the prolongation of evoked Ca2+ transient in response to stimulation,
leaving insufficient time for the evoked transient to return to base-
line before the next stimulus. Further, with relevance to outcome after
continuous haemodynamic interventions during and after rewarming,
we have reported spontaneous recovery of contractile dysfunction
and return of calcium overload during a 2-h follow-up period after
rewarming in these isolated, perfused and stimulated cells (Schaible
et al., 2016).
4.1 Summary and conclusion
The positive haemodynamic effects were both more pronounced
and more protracted with dextran than with crystalloid solution. In
addition, we measured significantly lower [Ca2+]i in cardiac tissue in
response to volume replacement, but post-hypothermic levels are still
substantially elevated. On this background, we advocate using volume
replacement aimed at maintaining euvolaemia during rewarming from
long-lasting accidental hypothermia.
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